Keywords: good, results, novartis, femara, swiss, drug, major

Good results for Novartis' Femara

Article | 19 December 2005

Print This

Swiss drug major Novartis says that women with hormone-sensitive early breast cancer who switched to its drug Femara (letrozole) from ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in